Skip to main content

Table 4 Target docking parameters and corresponding calculation results

From: Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network pharmacological analysis

Component

Target (gene symbol/protein name)

Binding energy (kJ/Mol)

ICS II

AKT1/RAC-alpha serine/threonine-protein kinase

-6.9

ICS II

BAD/Bcl2-associated agonist of cell death

-7.4

ICS II

MAPK1/Mitogen-activated protein kinase 1

-8.9

ICS II

PIK3CG/Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform

-9.6

ICS II

PRKG1/cGMP-dependent protein kinase 1

-9